Neuraxpharm Innovates Supply Chain with TraceLink MINT for Enhanced Data Exchange Neuraxpharm partners with TraceLink to streamline its supply chain through real-time data exchange, enhancing collaboration across global partners.

Neuraxpharm Innovates Supply Chain with TraceLink MINT for Enhanced Data Exchange #USA #Boston #Supply_Chain #TraceLink #Neuraxpharm

Wearable alert system for epileptics set for European launch An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.

#wearablehealthcare #epilepsy #mjnneuro #AI #wearabledevice #seizures #Episeras #mjnSERAS #medicaldevice #Neuraxpharm #drugresistantepilepsy #Bluetoothenabledearpiece #seizureriskdata #digitalhealthsolution #SERASHome_RWD #beyondthepill #EITHealth #Horizon2020programme
zurl.co/OKnrk

Neuraxpharm and mjn-neuro to Launch EPISERAS® Wearable for Early Seizure Detection EPISERAS® is an innovative digital health device for real-time seizure detection, promising improved safety and autonomy for epilepsy patients.

Neuraxpharm and mjn-neuro to Launch EPISERAS® Wearable for Early Seizure Detection #Germany #Düsseldorf #Neuraxpharm #mjn-neuro #EPISERAS

Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona Neuraxpharm highlights its dedication to multiple sclerosis treatment at ECTRIMS 2025 in Barcelona, showcasing innovative therapies in CNS disorders.

Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona #Spain #Barcelona #Multiple_Sclerosis #Neuraxpharm #ECTRIMS

Neuraxpharm's Strategic Launch in Australia to Enhance Global CNS Treatment Access Neuraxpharm continues its global expansion by launching Neuraxpharm Australia, focusing on CNS treatments like BRIUMVI and Nuvigil.

Neuraxpharm's Strategic Launch in Australia to Enhance Global CNS Treatment Access #Australia #Sydney #Neuraxpharm #CNS #BRIUMVI

Neuraxpharm and Dizlin Pharmaceuticals Forge a New Path in Parkinson's Care with Innovative Therapy Neuraxpharm and Dizlin Pharmaceuticals have teamed up to develop Infudopa SubC®, a breakthrough therapy for patients with advanced Parkinson's disease, enhancing patient independence.

Neuraxpharm and Dizlin Pharmaceuticals Forge a New Path in Parkinson's Care with Innovative Therapy #Germany #Düsseldorf #Parkinson's #Neuraxpharm #Dizlin

Neuraxpharm Expands its Portfolio with Acquisition of Narcolepsy Treatments Provigil® and Nuvigil® Neuraxpharm has announced the acquisition of Provigil® and Nuvigil®, enhancing their CNS portfolio and expanding into new markets like Australia.

Neuraxpharm Expands its Portfolio with Acquisition of Narcolepsy Treatments Provigil® and Nuvigil® #Neuraxpharm #Provigil #Nuvigil #Spain,_Germany #Barcelona,_Düsseldorf

Neuraxpharm and Pharmathen partner to develop long-acting injectable therapies - Pf Media Neuraxpharm and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies.

#mentalhealth #CNSdisorders #Neuraxpharm #Pharmathen #longactinginjectabletherapies #LATT #psychiatry #LATTprogram #shortactingdosageforms #prescribers #patientcompliance #LAI #LAIproducts #CNSproducts #CNSpatients #establishedtherapies #patientchoice
pf-media.co.uk/news/neuraxp...

Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy - PharmaTimes Promising results set stage for European marketing authorization

#Leriglitazone #cerebraladrenoleukodystrophy #cALD #CerebralALD #neurologicaldisorder #neurology #CNS
#MinoryxTherapeutics #Neuraxpharm #NEXUStrial #NEXUSclinicaltrial #CerebralALD #CerebralALDpatients #oncedailyoralleriglitazone #brainlesions #cALDstudies
pharmatimes.com/news/lerigli...

Neuraxpharm and Pharmathen Collaborate on Injectable Therapies for CNS Disorders Neuraxpharm and Pharmathen team up for developing long-acting injectable therapies aimed at enhancing treatment for CNS disorders, promoting patient compliance.

Neuraxpharm and Pharmathen Collaborate on Injectable Therapies for CNS Disorders #Neuraxpharm #Pharmathen #CNS #Barcelona,_Düsseldorf,_Athens

NICE endorses Neuraxpharm's ublituximab for treating MS - PharmaTimes New antibody therapy shows promise in managing condition

#NICEnews #NICErecommended #Neuraxpharm #ublituximab #BRIUMVI #MABS #MS #multiplesclerosis #MStreatment #multiplesclerosistreatment #patientoutcomes #antibodytherapy #NeuraxpharmGroup #relapsingremittingmultiplesclerosis #RRMS #MSpatients #TGTherapeutics
pharmatimes.com/news/nice-en...